Celgene Targets Doubling of Sales By 2017

Celgene (NASDAQ: CELG  ) has compiled preliminary 2012 results, and provided guidance for future periods that anticipates a doubling of sales by 2017, the company detailed in a press release. For fiscal 2012, the biotech firm believes it will post adjusted, diluted earnings per share of around $4.90, which is at the upper end of its previously-announced guidance range. Net product sales should come in at around $5.4 billion.

For future periods, the company anticipates it will post net product sales of $6 billion in 2013, an 11% increase on a year-over-year basis. Meanwhile, it is expecting EPS of $5.50-$5.60.

For 2017, Celgene has targeted a sales figure of $12 billion, double the expected level of 2013. It is also targeting EPS of $13-$14 that year.

The company will discuss its official 4Q and fiscal 2012 results in a conference call on January 24.


Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2183386, ~/Articles/ArticleHandler.aspx, 9/20/2014 4:18:54 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 19 hours ago Sponsored by:
DOW 17,279.74 13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASD 4,579.79 -13.64 -0.30%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/19/2014 3:59 PM
CELG $93.85 Up +0.58 +0.62%
Celgene CAPS Rating: *****

Advertisement